what

goal, team

A rare biotech startup, no external funding

regeneratics is a biotech startup focused on rejuvenation, debilitating diseases, and cancer through advanced bioinformatics, with particular emphasis on cardiovascular and immunological rejuvenation.

Academic pedigree

We are proud of our academic strength: national champions in mathematics and biochemistry; former university professors holding PhDs (summa cum laude) with more than five years of experience in cardiovascular and immuno-regenerative microbiology and computational biology; a distinguished professional with 40 years of experience in networking management across the lead technology and biotechnology sectors; and finally, experimental collaborators of excellence, (e.g., who have worked with the David Sinclair group and affiliated with Harvard Medical School).

business

1/3: membership, CSR

Members, not external investors

We describe regeneratics as “rare” because it does not follow the conventional startup path where investors request EBITDA, MVPs, or pitch decks. While side-projects surrounding the core entity do align with investor-oriented frameworks, the primary objective of regeneratics is not to maximise financial return, but to maximise biomedical impact through cellular rejuvenation—primarily via reprogramming.

Our mission is to optimise the health–time equation for our members. These include developers and professionals contributing to the mission, as well as financial members whose scarcest asset is time—particularly youth. regeneratics neither seeks direct funding nor offers equity. Membership benefits will be presented at a private, invitation-only inaugural event in October (Madrid, Spain).

Corporate Social Responsibility

We are committed to long-term impact and a responsible public image. Accordingly, we welcome strategic partnerships with institutions and organisations when the outcome delivers clear societal benefit—for example, initiatives addressing Long COVID.

business

2/3: side-projects

Side‑Projects (Investor‑Accessible)

These projects follow a more traditional, investment‑friendly structure. They are strategically necessary for regeneratics, either operationally or for capitalization, and are run as for‑profit entities that deliver services to the parent company at cost. Think of them as a top‑down approach to sustaining the core mission.

First example already completed: A blockchain platform for the securitization and tokenization of multiple ownership classes—intellectual, industrial, financial, and real‑estate. The platform is EVM‑compatible, user‑friendly, and allows seamless legal updates via smart contracts and web3 integration. Regulatory collaboration is underway with the Madrid Registry (Ilmo. Colegio de Registradores), alongside outreach to the notarial body and plans for full EU compliance. Discussions are also ongoing with tax authorities to ensure ecosystem‑wide integration.

Two more DeFi‑focused side‑projects are under development, offering novel solutions for decentralized financing. They will be announced once development is complete and strategic timing aligns.

business

3/3: services

Bioinformatics Services (Non‑core IP)

regeneratics provides bespoke analytics and advisory services in cellular regeneration and microbiology.

These offerings are designed to reduce experimental costs and trial repetition for pharmaceutical, academic, and biotech partners while protecting our proprietary technologies.

Leveraging multi‑omics integration, high‑throughput screening, and AI‑assisted pattern discovery, we deliver reproducible datasets, interactive notebooks, and optional wet‑lab validation protocols that traditional CROs cannot match.

Revenue from these B2B engagements directly funds our core longevity research roadmap without diluting equity or compromising scientific focus.

Finally, we are strengthen the network. We are currently in conversations with leading physicians and health cluster parties to design a specialised hospital that will facilitate early adoption of our cutting‑edge therapies—particularly the exclusive treatments reserved for members.